Clinical Trial Update: Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating oral Ifetroban for idiopathic pulmonary fibrosis (IPF), which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: RECRUITING